Theophylline/ephedra/hydroxyzine explained
Type: | combo |
Component1: | Theophylline |
Class1: | Stimulant |
Component2: | Ephedra (medicine) |
Class2: | Stimulant |
Component3: | Hydroxyzine |
Class3: | Antihistamine |
Tradename: | Marax |
Routes Of Administration: | By mouth |
Atc Prefix: | R03 |
Atc Suffix: | DA74 |
Cas Number: | 64095-02-9 |
Pubchemsubstance: | 135272520 |
Theophylline/ephedra/hydroxyzine (trade name Marax) is a drug that was used for the treatment of asthma. It was a combination of theophylline, ephedra,[1] and hydroxyzine, and taken by mouth.[2] [3] It is no longer manufactured in the US due to approval of ephedra being withdrawn by the FDA.
Notes and References
- Book: Hunt TM . Drug Games: The International Olympic Committee and the Politics of Doping, 1960–2008 . 2011 . University of Texas Press . 978-0-292-73957-4 . 45 . 20 July 2018 . en.
- Marax . Accessed 23 April 2021.
- Fixley M, Shen DD, Azarnoff DL . Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophylline . The American Review of Respiratory Disease . 115 . 6 . 955–62 . June 1977 . 262107 . 10.1164/arrd.1977.115.6.955 . 31 January 2024 .